The Health Section of today's Los Angeles Times reports on research to develop a new class of anti-depressant drugs that target not just the symptoms of depression but also its causes. As I read the article, I was surprised to see references to cortisol levels and Substance P. There was also some mention of pain, though the article seemed to regard the pain as a side effect of depression rather than the other way around. (I suspect either causative direction could be valid in any given case. The problem many of us with fibro face is the *assumption* that our pain results from depression and not the reverse.) Anyway, as I read the article, I found myself getting kind of excited by the idea that research into depression might open the door to greater understanding of fibromyalgia--and maybe even to treatments that are more effective and have fewer side effects. There is a very big market for anti-depressant drugs, which gives drug companies a big incentive to put money into more research. Wouldn't it be great if that research simultaneously came up with some answers for FM and CFIDS? Seems like a real possibility to me. In any event, given past discussion on this board about lack of research on fibro and CFIDS, I thought others might be interested in the article. To find the story, do a Google search for "Los Angeles Times" (without the quotation marks). Then use the search engine on the Times home page to look for "Searching for the Next Prozac" (again, without the quotation marks). Click on the article title to get to the story itself. Note: The Los Angeles Times keeps stories online for free only for seven days. So if you're interested, I suggest that you go to the site and download the story as soon as possible, even if you don't have a chance to read it right away. --Laura R.M.